Vice President, Clinical
Boston Scientific, Minnesota, United States
Dr. Dominic Allocco joined the Boston Scientific clinical team in July of 2006 and is currently Vice President of Clinical for the Cardiology division. His team is responsible for studies on coronary therapies, valvular heart disease and left atrial appendage closure. Dom received his BA in Economics from Harvard College and then received his MD from Stanford University. He also holds a MS in Engineering from Stanford University as well as a MS in Biomedical Informatics from the Massachusetts Institute of Technology. Dom completed residency training in Internal Medicine and fellowship training in Cardiology at Beth Israel Deaconess Medical Center in Boston. He is based in Minnesota.
Disclosure information not submitted.
Friday, March 8, 2024
2:15 PM – 3:45 PM ET
Discussion: Priorities for Structured DEI Enhancement in Shock Studies
Friday, March 8, 2024
3:05 PM – 3:45 PM ET
Focus 2024: The “Goldilocks” Use Case Construct
Saturday, March 9, 2024
1:35 PM – 1:45 PM ET
SESSION II: DIVERSITY EQUITY & INCLUSION (DEI) IN CV DEVICE RESEARCH
Saturday, March 9, 2024
2:05 PM – 3:05 PM ET
Saturday, March 9, 2024
2:45 PM – 3:05 PM ET
Overview Discussion, Comments & Next Steps
Saturday, March 9, 2024
6:40 PM – 7:00 PM ET
Panel Discussion: Will DCB Play a Role for Coronary Application in the US?
Sunday, March 10, 2024
10:55 AM – 11:10 AM ET
CARDIOTUBE INTERVIEW: AGENT IDE Update
Monday, March 11, 2024
3:45 PM – 4:00 PM ET
The ACURATE Neo 2: Next-Generation Improvements and Design Features
Tuesday, March 12, 2024
8:32 AM – 8:40 AM ET
Panel Discussion | Second- and Third-Generation Aortic Valve Systems Not Yet Approved in the US
Tuesday, March 12, 2024
9:36 AM – 10:15 AM ET
LAA Closure Beyond the WATCHMAN FLX Pro: Design Modifications and How to Reduce DRT
Tuesday, March 12, 2024
10:23 AM – 10:31 AM ET